KRAS Mutation as a Potential Prognostic Biomarker of Biliary Tract Cancers

BACKGROUND: The aim of this study was to identify the unique molecular characteristics of biliary tract cancer (BTC) for the development of novel molecular-targeted therapies. MATERIALS AND METHODS: We performed mutational analysis of KRAS, BRAF, PIK3CA, and FBXW7 and immunohistochemical analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Masaaki, Ohnishi, Hiroaki, Ohtsuka, Kouki, Matsushima, Satsuki, Ohkura, Yasuo, Furuse, Junji, Watanabe, Takashi, Mori, Toshiyuki, Sugiyama, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156551/
https://www.ncbi.nlm.nih.gov/pubmed/28008299
http://dx.doi.org/10.4137/JCM.S40549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156551/
https://www.ncbi.nlm.nih.gov/pubmed/28008299
http://dx.doi.org/10.4137/JCM.S40549

Ejemplares similares